Arthex Biotech

Development of microRNA Modulators for Diseases with Unmet Medical Needs

ARTHExt Biotech is a biotech spin-off from the University of Valencia (Spain) focused on researching and developing new therapies with oligonucleotides that modulate microRNA to treat diseases with unmet medical needs.

CEO
Frédéric Legros

WEBSITE
https://www.arthexbiotech.com/

INVESTED COMPANY
2023

DETAILS
Arthex Biotech
C/ Catedrático Agustín Escardino 9
46980 Paterna, Valencia (Spain)

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.